Valerio Therapeutics Société anonyme reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was EUR 11.64 million compared to EUR 11.47 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 EUR | -2.65% | -6.78% | -33.33% |
2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 18.09M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ALVIO Stock
- News Valerio Therapeutics
- Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023